Edition:
United States

USANA Health Sciences Inc (USNA.N)

USNA.N on New York Stock Exchange

137.14USD
28 Jul 2016
Change (% chg)

$-4.52 (-3.19%)
Prev Close
$141.66
Open
$139.37
Day's High
$139.40
Day's Low
$135.07
Volume
44,029
Avg. Vol
19,728
52-wk High
$176.84
52-wk Low
$92.56

Latest Key Developments (Source: Significant Developments)

Usana Health Sciences says Q2 earnings per share $2.07
Tuesday, 26 Jul 2016 04:20pm EDT 

Usana Health Sciences Inc : Company reiterated its consolidated net sales outlook for 2016 . Sees 2016 earnings per share between $7.90 and $8.20 . Usana health sciences reports record second quarter financial results . Q2 earnings per share $2.07 . Q2 sales $258.5 million versus i/b/e/s view $256.7 million . Q2 earnings per share view $2.05 -- Thomson Reuters I/B/E/S .Fy2016 earnings per share view $8.01, revenue view $1.02 billion -- Thomson Reuters I/B/E/S.  Full Article

USANA Health Sciences Increases Share Repurchase Authorization by $100 Million
Tuesday, 8 Dec 2015 07:00pm EST 

USANA Health Sciences:Says Board of Directors has authorized an additional $100 million in funding for share repurchases by the Company of its outstanding common stock.  Full Article

USANA Health Sciences Inc raises FY 2015 EPS guidance; raises low end of prior FY 2015 revenue guidance
Tuesday, 3 Nov 2015 04:17pm EST 

USANA Health Sciences Inc:Updated consolidated net sales and earnings per share outlook for FY 2015.Sees FY 2015 Consolidated net sales between $915 million and $920 million, versus the previous outlook of between $900 million and $920 million.Sees FY 2015 Earnings per share between $7.25 and $7.35, versus the previous outlook of between $6.90 and $7.20.FY 2015 revenue of $917 million and EPS of $7.16 - Thomson Reuters I/B/E/S.  Full Article

USANA board appoints Dave Wentz, Kevin Guest as co-CEO's
Tuesday, 4 Aug 2015 04:17pm EDT 

USANA Health Sciences Inc:Board of directors appoints dave wentz and kevin guest as co-chief executive officers.Says wentz will oversee usana's global operations.Says guest will lead usana's worldwide field development and sales efforts.Says paul jones, chief financial officer, has been appointed chief leadership development officer.Says jones will continue his CFO responsibilities while the company initiates a search for a new chief financial officer.  Full Article

USANA Health Sciences Inc raises FY 2015 guidance
Tuesday, 4 Aug 2015 04:07pm EDT 

USANA Health Sciences Inc:Expects FY 2015 consolidated net sales between $900 million and $920 million, versus the previous outlook of between $870 million and $890 million.Expects FY 2015 Earnings per share between $6.90 and $7.20, versus the previous outlook of between $6.45 and $6.75.FY 2015 revenue of $885 million and EPS of $6.70 - Thomson Reuters I/B/E/S.  Full Article

USANA Health Sciences Inc raises FY 2015 guidance
Tuesday, 5 May 2015 04:07pm EDT 

USANA Health Sciences Inc:Expects FY 2015 consolidated net sales between $870 million and $890 million, versus previous outlook of between $850 million and $870 million.Expects FY 2015 Earnings per share between $6.45 and $6.75, versus previous outlook of between $6.40 and $6.70.FY 2015 revenue of $851 million and EPS of $6.68 - Thomson Reuters I/B/E/S.  Full Article

USANA Health Sciences Inc gives FY 2015 mixed guidance
Tuesday, 10 Feb 2015 04:09pm EST 

USANA Health Sciences Inc:Expects FY 2015 consolidated net sales between $850 million and $870 million.Expects FY 2015 Earnings per share between $6.40 and $6.70.FY 2015 revenue of $824 million and EPS of $6.73 - Thomson Reuters I/B/E/S.  Full Article

USANA Health Sciences Inc raises low end of prior FY 2014 revenue guidance; raises FY 2014 EPS guidance
Tuesday, 28 Oct 2014 04:07pm EDT 

USANA Health Sciences Inc:Expects FY 2014 consolidated net sales between $780 million and $790 million, versus the previous outlook of between $770 and $790 million.Expects FY 2014 earnings per share between $5.85 and $5.95, versus the previous outlook of between $5.50 and $5.65.FY 2014 revenue of $770 million and EPS of $5.53 - Thomson Reuters I/B/E/S.  Full Article

BRIEF-Usana Health Sciences posts Q1 EPS of $1.77

* Usana Health Sciences reports first quarter financial results